Memantine HCl SR Pellets Manufacturer in India

Memantine HCl SR Pellets Manufacturer in India

Pharmaceutical-Grade Memantine HCl SR Pellets for Sustained-Release Oral Formulations

Memantine HCl SR Pellets are multiparticulate pharmaceutical formulations designed for sustained-release oral dosage applications. The active ingredient is Memantine Hydrochloride, identified by CAS Number 41100-52-1, molecular formula C₁₂H₂₂ClN, and molecular weight 215.76 g/mol. These chemical identifiers are confirmed by PubChem.

The SDP pellet product portfolio lists Memantine HCl SR Pellets in 8% and 10% strengths, providing multiple active-loading options for pharmaceutical formulation development.

The sustained-release pellet format provides a multiparticulate platform designed to modify the release profile of Memantine HCl. Such pellets can be incorporated into suitable oral dosage forms, including capsule-filling applications. Final release characteristics depend on the formulation composition, active loading, coating system, pellet characteristics and applicable finished-product specification.

Key Features

• Memantine HCl sustained-release pharmaceutical pellets
• Available in 8% and 10% strengths
• Pharmaceutical-grade multiparticulate formulation
• Sustained-release formulation platform
• Suitable for oral dosage-form development
• Suitable for capsule-filling applications
• Multiple active-loading options
• Product-specific release characteristics
• Formulation flexibility
• Suitable for bulk pharmaceutical requirements

Product Information

Memantine Hydrochloride is the hydrochloride salt of Memantine. PubChem identifies the compound as C₁₂H₂₂ClN, with molecular weight 215.76 g/mol and CAS Number 41100-52-1. The parent Memantine compound is separately identified by CAS 19982-08-2.

For the finished Memantine HCl SR Pellets, the 8% and 10% values represent active ingredient loading and should not be confused with the purity assay of Memantine Hydrochloride API.

Available Strengths

• Memantine HCl SR Pellets — 8%
• Memantine HCl SR Pellets — 10%

Applications

Memantine HCl SR Pellets can be considered for:

• Sustained-release oral formulation development
• Multiparticulate pharmaceutical formulations
• Capsule-filling applications
• Modified-release formulation development
• Oral dosage-form development
• Pharmaceutical formulation development
• Commercial pharmaceutical manufacturing

Why Memantine HCl SR Pellets from Swapnroop?

• Pharmaceutical-Grade Pellets: Designed for pharmaceutical formulation applications.
• 8% and 10% Strength Options: Provides flexibility in active ingredient loading.
• Sustained-Release Format: Designed for sustained-release multiparticulate applications.
• Multiparticulate Platform: Suitable for pellet-based oral dosage-form development.
• Product-Specific Quality Control: Finished pellets can be evaluated against applicable product specifications.
• Capsule-Filling Applications: Suitable for multiparticulate capsule formulation approaches.
• Bulk Pharmaceutical Supply: Suitable for formulation and manufacturing requirements.

Packaging & Supply

Memantine HCl SR Pellets can be supplied in suitable bulk packaging according to customer requirements. Strength, batch quantity, packaging configuration and applicable technical documentation can be specified according to the intended pharmaceutical formulation.

Get Bulk Quote via WhatsApp